A Study to Evaluate the Effects of Renal Function on Pharmacokinetics and Safety of DA-8010
NCT05812417 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 33
Last updated 2024-06-26
Summary
This Study will evaluate the effects of renal function on pharmacokinetics and safety of DA-8010
Conditions
- Renal Impairment
- Healthy
Interventions
- DRUG
-
DA-8010
DA-8010 5mg single dose administration
Sponsors & Collaborators
-
Dong-A ST Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- SCREENING
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-05-02
- Primary Completion
- 2024-06-07
- Completion
- 2024-06-07
Countries
- South Korea
Study Locations
More Related Trials
-
The Pharmacokinetics of D565 and the Drug Effect of D565 on Pharmacokinetic Characteristics of D930
NCT03034486 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2)
NCT04694989 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348
NCT04660370 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of Daptomycin in Healthy Chinese Subjects Living in China
NCT00858325 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of MK-8527 in Participants With Moderate and Severe Renal Impairment (MK-8527-008)
NCT06295796 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
NCT03210649 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2)
NCT06088017 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics (Drug Levels and Metabolism), Safety, and Tolerability of BMS-986259 in Participants With Various Levels of Kidney Function
NCT04237831 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects
NCT05812404 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-357 and D578 in Healthy Volunteers
NCT03671941 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3)
NCT05192356 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers
NCT03920579 ·Status: UNKNOWN ·Phase: PHASE1
-
A Multiple Dose Pharmacokinetic Study of Perampanel in Korean Healthy Subjects
NCT02020486 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Effect of Renal Function and Hemodialysis on the Pharmacokinetics (PK) of RO7079901
NCT02975388 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics and Safety of INCB054707 in Participants With Normal Hepatic Function and Participants With Hepatic Impairment
NCT05624710 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011
NCT02431481 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety, PK, PD and Food Effect Study of URC102 in Healthy Adults and Patients With Renal Impairment
NCT05198778 ·Status: COMPLETED ·Phase: PHASE1
-
A Study on the Effect of Renal Impairment on the Pharmacokinetics of RO4917838
NCT01510899 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Study in Healthy Participants and Participants With Kidney Dysfunction
NCT06383897 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)
NCT04883658 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
NCT02753504 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348
NCT04258865 ·Status: COMPLETED ·Phase: PHASE1
-
CKD-841 Pharmacokinetic/Pharmacodynamic Study
NCT03233932 ·Status: COMPLETED ·Phase: PHASE1
-
Compare the Pharmacokinetics and Safety of CKD-391
NCT04354987 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject.
NCT02623868 ·Status: COMPLETED ·Phase: PHASE1